Abstract. A review of the main elements determining strategic choices for the large-scale distribution of insecticidetreated nets (ITNs) clearly shows the need for multiple strategies. Mass distributions of free nets provide a unique opportunity to achieve quickly high coverage rates. However, there is also a need for additional approaches to 1) provide continuous provision of ITNs for newly pregnant women and their babies and 2) provide protection for the rest of the population. Targeted subsidies will continue to be an important tool to achieve the first objective, either through direct distribution of ITNs or through vouchers. To achieve objective 2, a strong and competitive commercial sector for ITNs seems to be a good option. It is clear that "one size doesn't fit all," and more experience needs to be gathered and shared. With planning and good promotion campaigns, these strategies can co-exist and re-enforce each other.
INTRODUCTION
The regular use of insecticide-treated nets (ITNs) is currently one of the two primary prevention tools against malaria in highly endemic areas of sub-Saharan Africa (SSA), along with indoor residual (house) spraying. Used properly, ITNs reduce child mortality by nearly a fifth and the number of clinical episodes by one half, with no evidence of a mortality delay effect. 1 A similarly high impact was seen under program conditions, 2 confirming the robustness of the trial impact data. As a result, ITNs have been recommended as one of the main malaria control tools by the Roll Back Malaria Partnership (RBM), with a special focus on the groups at highest risk: small children and pregnant women. Since then, the major issue for the international health community has been the national scaling up in all endemic areas, with the aim to protect the estimated 100 million children and pregnant women living in endemic areas in SSA (population at risk figure: Mapping Malaria Risk in Africa, www.mara.org). Protection with a fully effective ITN of all children in SSA would allow preventing ∼500,000 child deaths each year, 1 a major reduction in suffering and economic losses, and a crucial contribution toward the achievement of the millennium development goals.
How to achieve national scaling up of ITNs sustainably and with the best operational and financial efficiency has been the subject of many debates. 3, 4 Here we aim to contribute to one core element in this debate: should high-risk beneficiaries be expected to pay for their ITNs or should this be considered an essential public health good to be provided for free in a way similar to childhood vaccines or other routine interventions? We will focus this discussion on the provision of ITNs to defined high-risk groups, because this is where most public health gains can be made. In doing so we are not addressing the fact that ITNs are desirable for other age groups and that a high coverage with ITNs in the general population leads to an overall reduction in malaria transmission. This "mass effect" is well described in trial situations, 5, 6 and it does substantially enhance protection to both net users and non-users (GK Killeen and others, unpublished data).
Currently, a number of major distribution and financing models have been implemented, and they have provided a good body of global experience: 1) focus on commercial sector development (e.g., USAID-NetMark Project countries, www.netmarkafrica.org); 2) free distribution through public health facilities (e.g., Eritrea 7 ); 3) free distribution in the frame of measles vaccination campaigns (12 SSA countries thus far); 4) social marketing (e.g., Kenya); and 5) integrated approaches-more and more found in all countries because "pure" models are becoming rare (e.g., Ghana, Malawi, Tanzania). Unfortunately, the systematic description of these projects and their experience is beyond the scope of this paper.
The existing RBM framework for ITN upscaling prepared by the Working Group on Scalable Vector Control (RBM-WIN) outlines recommendations for tackling national upscaling on the basis of the existing experience. 8 Among the many considerations that are important for supporting large-scale ITN deployment, there is one that is central to our debate: the need to have rapid gains in coverage in all endemic countries, while at the same time, setting up systems that will ensure long-term availability (quick wins versus long-term sustainability). In addition, the impact (positive or negative) on the existing health system needs to be taken into account, but this aspect will not be discussed here. Finally, it is also necessary to outline a clearer vision for the future of ITNs as part of this debate.
ITNS: WHAT VISION?
How similar are ITNs and childhood vaccines? A view from the immunization perspective. Although there is some debate over the best methods of providing ITNs to children and pregnant women, there is no such ambiguity over how to vaccinate these same populations. In the early 1980s, vaccinations in Africa were mainly available through the private sector and some non-governmental organizations (NGOs). There was low coverage, poor quality of services, high cost, and inequity. In 1982, WHO's Expanded Program on Immunization (EPI)-with leadership from UNICEF and the consensus of donors-made a strategic decision that developing countries' vaccines would be both publicly financed and provided free to all women and children in the poorest countries. The rationale was that the benefits of high vaccination coverage were a public good and could only be achieved if all barriersincluding cost-were systematically removed. Public financing provided a mechanism for creating and supporting standardized vaccines, vaccination schedules, vaccine quality, and procurement systems. This led to economies of scale and an international program with common goals, methods, and standardized management practices. EPI has been sustained for 25 years and has resulted in relatively high coverage (> 50% globally in 1999, moving toward 77% in 2006 thanks to GAVI), with dramatic success in disease control. Today, ITN delivery resembles to some extent that of vaccines in the 1980s in that they are provided through a mix of public, private, and NGO delivery strategies, without a unified funding strategy and users having to pay at least a contribution in many situations. There is currently still low pan-African coverage, a significant cost to users, and demonstrable inequity in most settings. In addition, there is consensus among experts that there is not yet a sufficient standardization on products (although the way forward is clearly the shift toward longlasting insecticidal nets [LLIN]), procurement, and operational approaches.
An important issue is whether vaccines and ITNs are sufficiently similar that an EPI-like approach could be considered. Both target well people and not sick patients. Both can be delivered in campaigns, and in the case of the oral polio vaccine, with minimally trained community workers. Both interventions target the same priority population-children younger than 5 years of age. An additional public health advantage of ITNs is that they are available to all children who use the sleeping space they cover, not just the child to whom the net was "assigned." Table 1 compares key features of LLINs (improved ITNs that do not need to be retreated) and the commonly used pentavalent childhood vaccine (diphtheria-tetanus-Polio plus Haemophilus influenza and hepatitis B). Compared with the pentavalent vaccine, LLINs have a similar cost per death averted, while targeting largely the same population. If LLINs offer the same public health advantages as vaccines, perhaps they should receive the same approach to public financing and program management as vaccines.
ITNs as a commercial item: an alternative view. ITNs are life-saving tools that effectively prevent malaria. Before 2002, they were only available in most countries through geographically limited, publicly funded programs. Today, ITNs are widely available through the commercial sector in Africa, where they are sold at approximately US$4-5, which is less than what people paid for untreated nets in 2000. This development is largely the result of promotion through public/ private partnerships with a stronger market, increased competition, and extensive public education.
ITNs as a public good might be a moot point because there are neither systems in place nor long-term funding commitments to make them widely and indefinitely available. USAID-funded research in Ethiopia, Ghana, Mali, Nigeria, Senegal, and Uganda has shown that ITNs distributed through public sector channels are often sold for prices that approach commercial levels and often leak into the marketplace, where they are resold to higher-income families (www .netmarkafrica.org/research/index.html). Is this a good use of taxpayer money? At the same time, in Mali, one of the world's poorest countries, > 70% of all households own nets that were obtained through existing commercial outlets. These nets are often not treated with insecticide, but they do offer nevertheless a good level of protection. 1 ITNs have been effectively distributed for free through vaccination campaigns targeting the most vulnerable. This is a solid strategy to target children and should be expanded. However, this strategy ignores children who are born after a campaign and die before the next one. And, what about the older children in the family, or the wage-earners, all of whom are vulnerable to malaria and are left exposed? If they fall ill, the medical expenses, together with missed work and school, create an emotional and financial burden on the family and community.
Although we need to provide ITNs to those who cannot pay, we cannot make delivery of these products totally dependent on systems and funding sources that have repeatedly failed the people of SSA for the past 50 years. We cannot tell people to simply avoid mosquitoes before the next campaign reaches them. Mothers and fathers should have the possibility to purchase an inexpensive ITN through the same commercial sector that currently provides the vast majority of their goods and services. Uganda is a case in point, where promises by the public sector to distribute 1.8 million ITNs almost 3 years ago have not resulted in one person receiving a net. In the meantime, the commercial sector has sold > 3 million nets-unfortunately largely untreated because of the lack of a clear national policy. In the eight NetMark countries, retail sales have exceeded 19 million ITNs and 31 million untreated nets since 2002. In addition, African and international businesses have invested more than $44 million in country programs.
As countries attempt to rapidly scale up ITN coverage, they cannot neglect the short-and long-term benefits of using commercial channels as a complement to well-targeted distribution of free or nearly-free nets to the poorest of the poor. Commercial ITNs provide an option to families facing the threat of malaria. Taxpayers and the beneficiaries in developing countries need to look beyond this approach to ensure that, in pursuing "quick wins," we do not leave current and future generations vulnerable. In addition to a philosophical and strategic perspective, the sustainable large-scale deployment of ITNs can only take place in the frame of a strong enabling environment. 8 Recently, a systematic review of success factors in malaria control stressed the importance of conducive country conditions. 9 First, countries need to take a programmatic and national perspective, away from a project approach. From the onset, the strategies and activities need to be designed with national program size in mind, and most importantly, a strong government commitment at all levels.
Second, many actors will be relevant for planning national ITN upscaling, including government ministries, NGOs, researchers, bilateral and multilateral agencies, and other identified stakeholders. Strong stakeholder coordination is essential for the maximization of both process and impact, as shown, for example, in the case of Tanzania 10 or in other endemic countries. 9 This coordination process needs to be underpinned by a strong government leadership from within the country.
Third, it is essential that the government's commitment extends to developing a supportive legislative environment, including regulations for nets (requiring them to be of a certain quality and hopefully soon requiring them to be LLINs) and insecticide (which is needed to make use at household level possible), favorable trading conditions, and the removal of taxes and tariffs on all net and insecticide products (as agreed by all African governments in Abuja in 2000).
Finally, large national programs need a strong management structure (financial, logistical) supported by all national stakeholders, in the same way as EPI or other major public health programs. Good management, in turn, maximizes chances for ongoing funding of key activities at the required level-from national and international sources.
DISTRIBUTION OF FREE NETS THROUGH PUBLIC CHANNELS
In the same way as childhood vaccination relies on both routine EPI services and additional catch-up campaigns, a strategic vision for the deployment of ITNs through the public sector should aim at this dual approach.
Initial attempts at integrating EPI and ITN delivery have been encouraging, although largely restricted thus far to codistribution during measles catch-up vaccination campaigns. Table 2) .
The rate of use of these nets is at least similar to that of other delivery schemes, and coverage in children younger than 5 years of age has remained high in most settings: Lawra District in Ghana, 60% 11 ; Togo, 44%
12
; Zambia, 81%. 13 Interestingly, ITN coverage has remained high in the Lawra District in Ghana in all age groups even 3 years after mass distribution, in part because of follow-up ITN distribution activities (M Grabowsky and others, unpublished data). In Ghana and Zambia, long-term national promotion campaigns might also have contributed to these high use rates, a clear argument in favor of integrated campaigns. Protecting newly pregnant women and infants on a continuous basis is crucial because of the concentration of mortality in infants and the higher transmission rate (Figure 1) . Hence, mechanisms must be put in place to ensure the continuous provision of ITNs either for free or at very low cost to these children and their mothers. This can either be done through free distribution of LLINs or through some kind of a voucher scheme, allowing the project to devolve the complex task of supplying nets to the commercial sector. 10 Free distributions in the frame of catch-up vaccination campaigns are typically faster, achieve high coverage within weeks, are more equitable, and have the potential to be less expensive than other approaches because the costs are shared between a number of interventions. [11] [12] [13] Essentially, the Abuja targets have been reached in most of the countries that have adopted mass, free distribution to all children. The effect is further enhanced with the distribution of LLINs, which are easier to ensure in such campaigns. This approach has been endorsed by WHO, UNICEF, and the RBM Partnership.
A serious problem at present is the lack of evidence on how to proceed from a campaign mode to a continuous delivery mode. Wider adoption of free distribution of ITNs through EPI or other clinic-based approaches has been limited thus far to Eritrea, 7 whereas in Malawi, a co-payment of US$0.6 was requested.
14 To some extent, this topic has become entangled in the debate over whether ITNs should be free to all women and children. During vaccination sessions, all services must be free to avoid giving mothers the false impression that they may be paying for the vaccine, which might prevent the poor from coming back for subsequent vaccinations. Although sustainability remains a complex issue, there is at least a high level of agreement that ITNs given out during a vaccination contact will be used properly when supported by adequate education and promotion. If LLINs can be given out, the effect is maximized. Clearly, the massive free distribution of the nets raises substantial logistical issues, and there is empirical evidence that it might undermine the development of the commercial market (K Hanson and C Jones, unpublished data). A solution to both problems is the use of vouchers, which ensure a very inexpensive net to the beneficiary, while boosting the development of the commercial sector. 10, 13, 15 In Tanzania, high-value vouchers (US$2.50) are now given to pregnant women during their first antenatal care visit, as well as to the mothers of children coming for measles vaccination at 9 months. In addition, a campaign to give a free LLIN to every child younger than 5 years of age as a one-time "catch-up" event is also planned.
DEVELOPING THE COMMERCIAL SECTOR FOR ITNS
Although the African commercial sector is, in our experience, very efficient in delivering goods and services to even the poorest communities, it is typically fragmented and highly informal. It is found generally that distributors and wholesalers are generally passive and rely on multitudes of subdistributors and small retailers to come to them for stock. The retail network actors will not make products available in sufficient volume until they perceive that consumer demand exists, particularly given the bulkiness and the relatively high unit price of ITNs compared with other commonly stocked items like condiments and soap. The most important advantages of developing commercial markets for ITNs can be summarized into three categories: volume, cost, and sustainability.
Volume. The private sector has the potential to get ITNs distributed nationwide in most countries; from our observations, it can do so far more efficiently than the public sector. Well-established businesses in communities are more convenient and often more reliable than public clinics, where people must wait in long lines and be subjected to impersonal treatment, only to be handed an ITN that may or may not be the one they want. Private sector outlets provide consumers with choice in terms of brand, size, color, and price, so that each family can decide how and when to best meet its own needs. The private sector provides families with the opportunity to protect all of their members rather than limiting distribution to pregnant women and children younger than 5 years of age during irregular campaigns.
Cost. Distribution through the private sector reduces the cost of distribution of ITNs to donors and governments, allowing them to focus their limited resources on the poorest of the poor and the most vulnerable. Although the cost of distributed ITNs to donors can be as little as US$3.00-5.00, 14 additional costs of education and promotion are often not tracked or revealed, although they are essential for ensuring use and sustainability. Development of the private sector through partnership results in significant commercial investment, thereby increasing the impact of each dollar invested by the public sector. As for the cost to consumers, increased competition can result in improved products, increased availability, lower prices, and more choice.
Sustainability. Although there are huge financial resources being committed to ITN procurement today, there is always a danger that these investments will not continue for many years. While resources are available, we have a responsibility to build local capacity to deliver ITNs and educate populations about their effectiveness. There have been numerous examples in the past of donor-funded free distribution of products such as oral rehydration solution and contraceptives that have not been sustained. In the absence of private sector delivery, the end of funding means the end of options for vulnerable people.
On balance, the advantages to working with African businesses to build sustainable distribution networks for ITNs far outweigh the challenges and disadvantages. Building commercial distribution for ITNs in Africa, in coordination with targeted subsidy programs, is an essential element in the fight against malaria.
SUMMARY AND CONCLUSIONS
A successful ITN strategy to achieve and sustain high coverage consistent with the Abuja targets must address the following needs:
1. Rapidly achieving high and equitable coverage 2. Assuring that all newborns and pregnant women have access to a long-lasting ITN on a continuous basis 3. Assuring that nets are properly and consistently used 4. Ensuring access to ITNs for the rest of the population at an affordable cost This is a considerable challenge, the difficulty of which is attested to by the fact that it has rarely been achieved as of 2007. Our review with a double focus confirms the widely held view that no single approach is likely to bring the perfect solution to such a complex problem. In this light, the best way to achieve sustainable malaria prevention is to mobilize all available resources and partners through a coordinated strategy based on the local context. There is also an urgent need to learn more about large-scale program experience and debate the findings. There is very clearly a need for a rapid catch-up strategy because African rates of ITN use have remained too low for far too long. More than 10 years after conclusive proof of their efficacy, ITNs are used on average by < 10% of high-risk individuals in endemic areas. This is simply unacceptable.
Mass distributions associated with measles vaccination or any other strategy of "catching-up" provide a unique opportunity to rapidly scale up ITN use.
At the same time, there is a need for additional approaches to 1) provide continuous provision of long-lasting ITNs for newly pregnant women and their babies and 2) provide protection to the rest of the population. In the absence of sufficient long-term funds to provide free nets to all, targeted subsidies will continue to be an important tool to achieve the first objective, either through the direct distribution of a longlasting ITN (usually through clinics) or through the use of publicly funded vouchers redeemable through retail outlets. To achieve objective 2, a strong and competitive commercial sector for nets seems to be a good strategy.
With a minimum of planning and good public promotion campaigns, these strategies can co-exist and even re-enforce each other. This leads to a clear vision, shared widely within the international health community: "All people exposed to malaria in Africa will own and use mosquito nets, either as long-lasting insecticidal nets or regularly re-treated. Those most vulnerable to malaria will not be excluded from owning an ITN due to cost. Through public sector subsidies, vulnerable groups will be able to obtain ITNs at little or no cost to them through public channels (e.g., EPI or ANC), sometimes in the form of a voucher and sometimes in the form of the ITN itself. Within the commercial market, prices will be kept as low as possible by economies of scale and competition at all levels." 8 Finally, governments will help by providing an "enabling environment" and the international community should ensure appropriate funding of sound programs.
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